Cancer Treatment Delays: UK Misses Targets

Performance in England's cancer treatment has declined, with only 69.9% of patients beginning treatment within the 62-day target timeframe, a decrease from the previous 71.9%. This trend contrasts with government ambitions set out in the National Cancer Plan and NHS Planning Guidance, which aimed for 80% of patients to start treatment within 62 days by March 2027, and 85% by March 2027.

Experts like Prof Pat Price criticize the current situation, calling the targets "impossible to hit" due to a "complete lack of a plan or accountability." Radiotherapy UK analysis suggests over 3,000 additional patients monthly are needed to meet the March 2027 target, a figure expected to rise as referrals increase.

One patient, Alan, experienced significant delays for lung cancer surgery, with his cancer spreading during the wait, leading to more complex surgery and ongoing pain. The article highlights the struggles of various NHS trusts facing pressures from rising demand, workforce shortages, and diagnostic bottlenecks.

Salisbury NHS trust is making some progress on waiting lists but still misses targets. They focus on operational basics like appointment attendance, IT system functionality, recruitment, and capacity expansion. Innovations in skin and prostate cancer treatment, such as intraoperative margin checks, are being implemented.

Despite efforts, bottlenecks persist in pathology labs due to specimen volume and a need for more staff and equipment. Radiotherapy also faces challenges, with patients needing to travel to other cities for daily sessions. Missed appointments, due to various reasons including anxiety and transport issues, further strain the system. Macmillan Cancer Support emphasizes the need for government to match its ambitions with urgency and visible progress on establishing a National Cancer Board.